Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Lessons for human diabetes from experimental mouse models.

Kulkarni RN, Zisman A.

Curr Diab Rep. 2003 Apr;3(2):168-75. Review.

PMID:
12728643
2.

Gene and cell therapies for diabetes mellitus: strategies and clinical potential.

Giannoukakis N, Robbins PD.

BioDrugs. 2002;16(3):149-73. Review.

PMID:
12102644
3.

[Gene therapy for diabetes].

Moritani M, Itakura M.

Nihon Rinsho. 1997 Nov;55 Suppl:739-45. Review. Japanese. No abstract available.

PMID:
9434557
4.

Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.

Giannoukakis N, Pietropaolo M, Trucco M.

Diabetes Nutr Metab. 2002 Jun;15(3):173-203. Review.

PMID:
12173733
5.

Genetically engineered mice as animal models for NIDDM.

Joshi RL, Lamothe B, Bucchini D, Jami J.

FEBS Lett. 1997 Jan 20;401(2-3):99-103. Review.

6.

Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells.

Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller JF.

Nature. 1988 Jun 9;333(6173):529-33.

PMID:
3287175
7.

Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Lampeter EF, Signore A, Gale EA, Pozzilli P.

Diabetologia. 1989 Oct;32(10):703-8. Review.

PMID:
2687059
8.

Transgenic mouse models of type I diabetes.

Lipes MA, Eisenbarth GS.

Diabetes. 1990 Aug;39(8):879-84. Review.

PMID:
2197138
9.

Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.

Giannoukakis N, Pietropaolo M, Trucco M.

Curr Opin Investig Drugs. 2002 May;3(5):735-51. Review.

PMID:
12090547
10.

[Diabetes mellitus and cellular immunity].

Paknys G, Kondrotas AJ, Kevelaitis E.

Medicina (Kaunas). 2006;42(1):1-10. Review. Lithuanian.

11.

[The natural history of diabetes with respect to disorders of insulin function].

Dorner M, Pinget M, Brogard JM, Sapin R, Paris-Bockel D, Levy P, Jung C.

Journ Annu Diabetol Hotel Dieu. 1984:51-71. Review. French. No abstract available.

PMID:
6399540
12.
13.

The stages of type 1A diabetes: 2005.

Gianani R, Eisenbarth GS.

Immunol Rev. 2005 Apr;204:232-49. Review.

PMID:
15790362
14.

Transgenic models of diabetes.

Sarvetnick N.

Curr Opin Immunol. 1989-1990 Apr;2(4):604-6. Review. No abstract available.

PMID:
2517914
15.

Gene therapy for diabetes mellitus.

Docherty K.

Clin Sci (Lond). 1997 Apr;92(4):321-30. Review.

PMID:
9176029
16.
17.

Role of beta-cells in type 1 diabetes pathogenesis.

Faideau B, Larger E, Lepault F, Carel JC, Boitard C.

Diabetes. 2005 Dec;54 Suppl 2:S87-96. Review.

18.

Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.

Piaggio E, Hartemann-Heurtier A, Cabarrocas J, Desbois S, Mars LT, Zappulla JP, Liblau RS.

J Autoimmun. 2004 Mar;22(2):115-20. Review. No abstract available.

PMID:
14987739
19.

Experimental models of type-I diabetes.

Bach JF, Boitard C.

Pathol Immunopathol Res. 1986;5(3-5):384-415. No abstract available.

PMID:
3110756
20.

Gene therapy in type 1 diabetes.

Bagley J, Paez-Cortez J, Tian C, Iacomini J.

Crit Rev Immunol. 2008;28(4):301-24. Review.

PMID:
19166382
Items per page

Supplemental Content

Write to the Help Desk